Baker Brothers Life Sciences LP, Director, 10% Owner at Kodiak Sciences Inc. (KOD), bought 892,911 shares at $5.71 ($5.3M) on 2022-05-16, disclosed to the SEC on 2022-05-18.
Open-market purchase of $5.3M KOD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.71 | 11,410 | $65K | 1.2% |
| 2 | $5.71 | 93,690 | $535K | 10.1% |
| 3 | $5.71 | 93,690 | $535K | 10.1% |
| 4 | $5.71 | 11,410 | $65K | 1.2% |
| 5 | $5.75 | 15,154 | $87K | 1.7% |
| 6 | $5.75 | 15,154 |
| $87K |
| 1.7% |
| 7 | $5.75 | 1,846 | $11K | 0.2% |
| 8 | $5.99 | 90,674 | $543K | 10.3% |
| 9 | $5.99 | 989 | $6K | 0.1% |
| 10 | $5.99 | 8,118 | $49K | 0.9% |
| 11 | $5.99 | 11,043 | $66K | 1.3% |
| 12 | $5.99 | 11,043 | $66K | 1.3% |
| 13 | $5.99 | 90,674 | $543K | 10.3% |
| 14 | $5.95 | 9,157 | $54K | 1.0% |
| 15 | $5.95 | 9,157 | $54K | 1.0% |
| 16 | $5.95 | 1,115 | $7K | 0.1% |
| 17 | $5.97 | 22,266 | $133K | 2.5% |
| 18 | $5.97 | 182,827 | $1.1M | 20.7% |
| 19 | $5.97 | 912 | $5K | 0.1% |
| 20 | $5.97 | 182,827 | $1.1M | 20.7% |
| 21 | $5.97 | 7,489 | $45K | 0.8% |
| 22 | $5.97 | 22,266 | $133K | 2.5% |
| Total | $5.91 avg | 892,911 | $5.3M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |